Patents by Inventor Guo Huang

Guo Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11657480
    Abstract: For an ultrasound image acquired by an ultrasound detection system, background data with small noises are first filtered. Next, a binary image is generated by performing image binarization on the noise-reduced ultrasound image based on a first threshold value, wherein the binary image contains information associated with the body of high-echo foreground images in the ultrasound image. An output image is generated by performing foreground expansion on the binary image based on the pixel value of the ultrasound image and a second threshold value smaller than the first threshold value, wherein the output image contains information associated with not only the body but also the outline of high-echo foreground images in the ultrasound image. An improved ultrasound image is generated by performing a post-processing on the ultrasound image according to information of foreground and non-foreground region in the output image.
    Type: Grant
    Filed: December 23, 2020
    Date of Patent: May 23, 2023
    Assignee: Qisda Corporation
    Inventors: Ssu-Hua Huang, Jian-Guo Huang
  • Publication number: 20210256660
    Abstract: For an ultrasound image acquired by an ultrasound detection system, background data with small noises are first filtered. Next, a binary image is generated by performing image binarization on the noise-reduced ultrasound image based on a first threshold value, wherein the binary image contains information associated with the body of high-echo foreground images in the ultrasound image. An output image is generated by performing foreground expansion on the binary image based on the pixel value of the ultrasound image and a second threshold value smaller than the first threshold value, wherein the output image contains information associated with not only the body but also the outline of high-echo foreground images in the ultrasound image. An improved ultrasound image is generated by performing a post-processing on the ultrasound image according to information of foreground and non-foreground region in the output image.
    Type: Application
    Filed: December 23, 2020
    Publication date: August 19, 2021
    Inventors: Ssu-Hua Huang, Jian-Guo Huang
  • Patent number: 9269515
    Abstract: An insulating cylinder and a main circuit structure using the insulating cylinder includes a main cavity, a secondary grounded insert connected with the main cavity, an arc-distinguishing chamber connected with the main cavity, and an outlet terminal insert connected with an end of the arc-distinguishing chamber. An observation window is provided at a side of the main cavity. A main circuit structure using the insulating cylinder, which further includes a main grounded rod and a main grounded contact positioned in the main cavity, an arc-distinguishing chamber insulating pole, an isolated insulating pole, an isolated conductive block, an isolated rod and an isolated contact, and a main bus-bar bushing connected with the isolated contact. A flexible connection is provided between the main grounded contact, the arc-distinguishing chamber and the isolated conductive block.
    Type: Grant
    Filed: July 30, 2013
    Date of Patent: February 23, 2016
    Assignee: BEIJING HUADONG SENYUAN ELECTRIC CO., LTD.
    Inventors: Chuang Guo Huang, Shu Xuan Shi, Guo Yan Xu
  • Publication number: 20140175059
    Abstract: An insulating cylinder and a main circuit structure using the insulating cylinder includes a main cavity, a secondary grounded insert connected with the main cavity, an arc-distinguishing chamber connected with the main cavity, and an outlet terminal insert connected with an end of the arc-distinguishing chamber. An observation window is provided at a side of the main cavity. A main circuit structure using the insulating cylinder, which further includes a main grounded rod and a main grounded contact positioned in the main cavity, an arc-distinguishing chamber insulating pole, an isolated insulating pole, an isolated conductive block, an isolated rod and an isolated contact, and a main bus-bar bushing connected with the isolated contact. A flexible connection is provided between the main grounded contact, the arc-distinguishing chamber and the isolated conductive block.
    Type: Application
    Filed: July 30, 2013
    Publication date: June 26, 2014
    Applicant: Beijing Huadong Senyuan Electric Co., Ltd.
    Inventors: Chuang Guo HUANG, Shu Xuan SHI, Guo Yan XU
  • Patent number: 8283374
    Abstract: The present invention relates to processes for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl)acetylguanidine derivatives of the formula I via 3-hydroxy-2,3-dihydro-1H-isoindol-1-one derivatives or 3-(2-carbamoylphenyl)-acrylic ester derivatives as intermediates, to a process for optical resolution, and to intermediates of the process according to the invention.
    Type: Grant
    Filed: April 2, 2009
    Date of Patent: October 9, 2012
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Gerrit Schubert, Joerg Rieke-Zapp, Johannes Keil, Heinz-Werner Kleemann, Reda Hanna, Bao-Guo Huang, Xiao-Dong Wu, Yves Gouraud
  • Publication number: 20100184979
    Abstract: This invention is directed to a process for preparing 2-(3-{6-[2-(2,4-dichloro-phenyl)-ethylamino]-2-methoxy-pyrimidin-4-yl}-phenyl)-2-methyl-propionic acid.
    Type: Application
    Filed: December 16, 2009
    Publication date: July 22, 2010
    Applicant: SANOFI-AVENTIS
    Inventors: Reda G. HANNA, Elizabeth SECORD, Bao-Guo HUANG, Matthew R. POWERS
  • Patent number: 7626027
    Abstract: The present invention discloses and claims compounds of formula (I) wherein M is N, and K and L are each C with the remaining substituents further defined herein. These compounds are effective as inhibitors of human casein kinase I?, and as such are useful in the treatment of central nervous system diseases and disorders including mood disorders and sleep disorders. Pharmaceutical compositions comprising compounds of formula (I) and methods for the preparation of compounds of formula (I) are also disclosed and claimed.
    Type: Grant
    Filed: April 21, 2008
    Date of Patent: December 1, 2009
    Assignee: Aventis Pharmaceuticals Inc
    Inventors: William A. Metz, Jr., Frank Halley, Gilles Dutruc-Rosset, Yong Mi Choi-Sledeski, Gregory Bernard Poli, David Marc Fink, Gilles Doerflinger, Bao-Guo Huang, Ann Marie Gelormini, Juan Anotonio Gamboa, Andrew Giovanni, Joachim E. Roehr, Joseph T. Tsay, Fernando Camacho, William Joseph Hurst, Stephen Wayne Harnish, Yulin Chiang
  • Patent number: 7592039
    Abstract: There are provided a method capable of mass-producing a nanotube material easily with low costs, and a nanotube material. The method of the present invention for producing a nanotube material has at least forming a metal oxide thin film or an organic/metal oxide composite thin film on an inner wall of a porous substrate and removing the porous substrate. The nanotube material of the invention has a structure provided from a body comprising a metal oxide thin film or an organic/metal oxide composite thin film formed on an inner wall of the porous substrate, from which a portion corresponding to the porous substrate is removed.
    Type: Grant
    Filed: March 17, 2004
    Date of Patent: September 22, 2009
    Assignee: Riken
    Inventors: Jian-guo Huang, Toyoki Kunitake
  • Publication number: 20090203761
    Abstract: The present invention relates to processes for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl)acetylguanidine derivatives of the formula I via 3-hydroxy-2,3-dihydro-1H-isoindol-1-one derivatives or 3-(2-carbamoylphenyl)-acrylic ester derivatives as intermediates, to a process for optical resolution, and to intermediates of the process according to the invention.
    Type: Application
    Filed: April 2, 2009
    Publication date: August 13, 2009
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Gerrit SCHUBERT, Joerg RIEKE-ZAPP, Johannes KEIL, Heinz-Werner KLEEMANN, Reda HANNA, Bao-Guo HUANG, Xiao-Dong WU, Yves GOURAUD
  • Patent number: 7531569
    Abstract: A method and apparatus for preventing board warpage during the application and curing or drying of liquid epoxies, or the like, on printed circuit boards using a clamping fixture assembly, which includes at least one clamping fixture support and at least one clamping fixture overlay. If desired, a plurality of printed circuit boards may be processed using an appropriate clamping fixture assembly. Furthermore, the clamping fixture may be constructed so a slight bow or curvature thereof can counter either a convex or concave bow or curvature of the printed circuit board. In the method, at least one printed circuit board is mounted to a clamping fixture support whereby a clamping fixture overlay is placed on top of the first printed circuit board.
    Type: Grant
    Filed: December 1, 2004
    Date of Patent: May 12, 2009
    Assignee: sanofi-aventis Deutschland GmbH
    Inventors: Gerrit Schubert, Joerg Rieke-Zapp, Johannes Keil, Heinz-Werner Kleemann, Reda Hanna, Bao-Guo Huang, Xiao-Dong Wu, Yves Gouraud
  • Publication number: 20080200496
    Abstract: The present invention discloses and claims compounds of formula (I) wherein M is N, and K and L are each C with the remaining substituents further defined herein. These compounds are effective as inhibitors of human casein kinase I?, and as such are useful in the treatment of central nervous system diseases and disorders including mood disorders and sleep disorders. Pharmaceutical compositions comprising compounds of formula (I) and methods for the preparation of compounds of formula (I) are also disclosed and claimed.
    Type: Application
    Filed: April 21, 2008
    Publication date: August 21, 2008
    Applicant: AVENTIS PHARMACEUTICALS INC.
    Inventors: William A. METZ, Frank HALLEY, Gilles DUTRUC-ROSSET, Yong Mi CHOI-SLEDESKI, Gregory Bernard POLI, David Marc FINK, Gilles DOERFLINGER, Bao-Guo HUANG, Ann Marie GELORMINI, Juan Antonio GAMBOA, Andrew GIOVANNI, Joachim E. ROEHR, Joseph T. TSAY, Fernando CAMACHO, William Joseph HURST, Stephen Wayne HARNISH, Yulin CHIANG
  • Patent number: 7402672
    Abstract: The present invention discloses and claims compounds of formula (I) as inhibitors of human casein kinase IF, and methods of using said compounds of formula (I) for treating central nervous system diseases and disorders including mood disorders and sleep disorders. Pharmaceutical compositions comprising compounds of formula (I) and methods for the preparation of compounds of formula (I) are also disclosed and claimed.
    Type: Grant
    Filed: December 1, 2004
    Date of Patent: July 22, 2008
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: William A. Metz, Jr., Frank Halley, Gilles Dutruc-Rosset, Yong Mi Choi-Sledeski, Gregory Bernard Poli, David Marc Fink, Gilles Doerflinger, Bao-Guo Huang, Ann Marie Gelormini, Juan Antonio Gamboa, Andrew Giovanni, Joachim E. Roehr, Joseph T. Tsay, Fernando Camacho, William Joseph Hurst, Stephen Wayne Harnish, Yulin Chiang
  • Publication number: 20080038492
    Abstract: There are provided a method capable of mass-producing a nanotube material easily with low costs, and a nanotube material. The method of the present invention for producing a nanotube material has at least forming a metal oxide thin film or an organic/metal oxide composite thin film on an inner wall of a porous substrate and removing the porous substrate. The nanotube material of the invention has a structure provided from a body comprising a metal oxide thin film or an organic/metal oxide composite thin film formed on an inner wall of the porous substrate, from which a portion corresponding to the porous substrate is removed.
    Type: Application
    Filed: March 17, 2004
    Publication date: February 14, 2008
    Applicant: Riken
    Inventors: Jian-guo Huang, Toyoki Kunitake
  • Publication number: 20070212514
    Abstract: There is disclosed a method for producing a thin film material, comprising plugging pores in a surface of a porous substrate with a polymer compound, forming a metal oxide thin film or an organic/metal oxide composite thin film on the plugged porous substrate, and removing the polymer compound or both of the polymer compound and an organic compound in the thin film. The metal oxide thin film or the organic/metal oxide composite thin film can be uniformly formed without defects directly on the porous substrate by the method.
    Type: Application
    Filed: May 28, 2004
    Publication date: September 13, 2007
    Applicant: Riken
    Inventors: Jian-guo Huang, Toyoki Kunitake
  • Publication number: 20070171837
    Abstract: A real-time ring-loop surveillance network system is provided. By using digital communication network, multiple channels of media data and control data are transmitted in a ring-loop. The media data includes any forms of digital audio and video data, which is transmitted through 802.3/802.3u physical layer interface. The media data reaches all the stations in the network at the same time, and the number of the stations in the system depends on the system requirements. The number of the channels depends on the transceiver's speed. The present invention defines frames to encompass the media data and control data for transmission. The point-to-point delay is less than 0.15 ms. When 32 stations are connected in a ring-loop, the maximum delay is less than 5 ms. A backup mechanism is also included to detect and automatically switch to maintain the normal operation of the surveillance network system. The monitor signals are also encompassed in frames transmitted in the same network.
    Type: Application
    Filed: March 24, 2006
    Publication date: July 26, 2007
    Applicant: PENTON MEDIA TECHNOLOGIES CO., LTD.
    Inventors: L. Chen, Guo Huang
  • Patent number: 7186705
    Abstract: The present invention relates to a process for the preparation of 3-amino-2-hydroxypropylphosphinic acid derivatives of the formula I, which are valuable pharmaceutical active ingredients and can be used, for example, as antidepressants. The process starts from O-ethyl phosphinates of the formula II into which, after silylation with hexamethyldisilazane, the 3-amino-2-hydroxypropyl moiety is introduced by reactions with epichlorohydrin and ammonia.
    Type: Grant
    Filed: September 22, 2004
    Date of Patent: March 6, 2007
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Bao-Guo Huang, Witold Subotkowski, Duane Rudisill
  • Patent number: 7004060
    Abstract: A balancing vertical load device for a motor, to be used in conjunction with a vertical driving device with a force- and position-controlled motor, comprising a motor assembly and a sealed air pressure system. The motor assembly has a motor, and a load weight which, driven by the motor, performs a vertical movement. The sealed air pressure system has an air cylinder, a piston, gliding inside the air cylinder with low friction and being connected with the load weight, an air container, storing a relatively large air volume, and an air pressure source. The sealed air pressure system balances a load of the load weight, so that precise control of force and position of a vertically moving object, as if moving horizontally, is achieved.
    Type: Grant
    Filed: November 4, 2003
    Date of Patent: February 28, 2006
    Assignee: Industrial Technology Research Institute
    Inventors: Guo-Shing Huang, Chun-Ming Li, Gia-Hung Hung, Hung-I Lin, Ching-Guo Huang
  • Publication number: 20050131012
    Abstract: The present invention discloses and claims compounds of formula (I) as inhibitors of human casein kinase IF, and methods of using said compounds of formula (I) for treating central nervous system diseases and disorders including mood disorders and sleep disorders. Pharmaceutical compositions comprising compounds of formula (I) and methods for the preparation of compounds of formula (I) are also disclosed and claimed.
    Type: Application
    Filed: December 1, 2004
    Publication date: June 16, 2005
    Applicant: Aventis Pharmaceuticals Inc.
    Inventors: William Metz, Frank Halley, Gilles Dutruc-Rosset, Yong Choi-Sledeski, Gregory Bernard Poli, David Fink, Gilles Doerflinger, Bao-Guo Huang, Ann Gelormini, Juan Gamboa, Andrew Giovanni, Joachim Roehr, Joseph Tsay, Fernando Camacho, William Hurst, Stephen Harnish, Yulin Chiang
  • Patent number: RE44784
    Type: Grant
    Filed: August 23, 2011
    Date of Patent: March 4, 2014
    Assignee: DPDP, LLC
    Inventors: Jian Guo Huang, Fox Marshall
  • Patent number: D946788
    Type: Grant
    Filed: April 9, 2021
    Date of Patent: March 22, 2022
    Inventor: Guo Huang